This study explored the effect of the methylenetetrahydrofolate reductase (MTHFR) 677C-->T polymorphism on plasma homocysteine levels in response to folic acid supplementation in patients with cardiovascular disease. A total of 23 patients, aged 44-88, were supplemented with 5 mg of folic acid daily for 8 weeks. Plasma homocysteine levels decreased
